Evolus inc.

Major-Pharmaceuticals

EOLS


520 Newport Center Drive
Newport Beach , CA 92660

Executive/
Director

Price

  • Last Close
  • $ 11.5
    $ +0.39 3.51 %
    Jan 3, 2025
  • 52-Week High/Low
  • $16.15 - $7.6
  • YTD
  • 4.1%

  • Trading Volume
  • 48,558
  • Market Cap Full
  • $ 657.2M
  • Shares Outstanding
  • 57.2M
    Nov 3, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - 89.7% -5% 265.9% 72.4% 12.7% 32.9% 4.1%
Q2 - - 209.3% -38.3% 4% 3.8% 3.4% -14.1% -20.5% -
Q3 - - -37.6% 3.3% 8% -39.8% -30.6% 25.7% 10.2% -
Q4 - - -37.5% -20.3% -13% -14.6% -6.7% 21.5% -9.3% -
J F M A M J J A S O N D
2025 4.1% - - - - - - - - - - -
2024 20.5% 16.9% -5.7% -17.6% 12.1% -15.6% 31.6% 10.2% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%5%-73%95%15%40%5%4%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -0.3 -0.4 -0.59 0.16 -0.31 -0.26
Q2 - - -0.69 -1.37 -0.63 -0.31 -0.42 -0.32
Q3 - - -0.48 -0.98 -0.34 -0.35 -0.36 -0.30
Q4 - 0.24 -0.45 -0.44 -3.27 -0.44 -0.24 -
A 0 0.2 -1.9 -3.2 -4.8 -0.9 -1.3 -0.88

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 27.3 33.7 43.7 55.7 56.4
Jun 23.6 27.3 33.7 54.1 56 56.9
Sep 26.7 27.4 33.7 54.6 56.1 57
Dec 27.3 27.4 33.7 55.6 56.2 57.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 3 22 6 1.3 -
Fixed Asset Turnover 24.8 25 57 11.7 -
Total Asset Turnover 0.8 0.4 0.3 0.2 -
Leverage
Debt Ratio 0.7 0.4 - 0.5 -
Debt – Equity Ratio 3.8 0.9 - 0.9 -
Interest Coverage -7.2 -14.7 -15.3 11 -46
Equity multiplier 0.3 0.1 - - -